Sightera Biosciences Pre-Seed

Sightera Biosciences, an AI drug discovery startup, has secured €3 million in pre-Seed funding led by Entourage, Anacura, and QBIC. This marks the company's first external funding round. The capital will be used to expand its team, accelerate its AI-native drug discovery platform, advance its lead oncology program towards preclinical candidate selection, and build strategic partnerships.